Genetic/congenitalTSC Alliance and Apertura Gene Therapy collaboration progressesTSC Alliance and Apertura Gene Therapy LLC have announced progress in their collaboration to advance gene therapies to treat tuberous sclerosis complex (TSC) with the completion of a preclinical pilot study evaluating an AAV gene therapy approach for TSC1.